Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	258,178	237,046	204,567	166,141	96,135	69,112
Short-Term Investments	80	60	4,479	-	20	60
Cash & Short-Term Investments	258,258	237,106	209,046	166,141	96,155	69,172
Cash Growth	41.82%	13.42%	25.82%	72.78%	39.01%	8.04%
Receivables	119,681	145,936	135,022	136,066	114,396	99,788
Inventory	53,403	57,451	74,864	48,629	44,814	41,817
Prepaid Expenses	-	15,426	20,670	14,699	10,465	10,952
Other Current Assets	29,191	12,389	15,502	48,061	79,271	59,537
Total Current Assets	460,533	468,308	455,104	413,596	345,101	281,266
Property, Plant & Equipment	99,223	101,419	105,721	104,752	108,420	112,131
Long-Term Investments	97,411	104,793	100,975	297,170	324,178	255,997
Goodwill	22,295	22,654	21,186	-	-	-
Other Intangible Assets	342,637	353,581	330,041	57,288	69,134	64,734
Long-Term Deferred Tax Assets	58,269	55,759	51,020	40,863	35,604	25,074
Other Long-Term Assets	11,006	1	-1	-1	-	1
Total Assets	1,091,374	1,106,515	1,064,046	913,668	882,437	739,203

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	53,726	62,951	89,329	60,691	66,794	49,689
Accrued Expenses	-	23,787	19,350	13,493	11,726	10,824
Short-Term Debt	40,505	5,389	-	-	-	-
Current Portion of Long-Term Debt	-	30,000	30,000	-	-	-
Current Portion of Leases	2,671	3,078	3,178	2,310	2,490	2,301
Current Income Taxes Payable	17,611	35,890	4,319	24,518	40,896	2,284
Other Current Liabilities	24,326	2,550	2,120	2,612	1,023	828
Total Current Liabilities	138,839	163,645	148,296	103,624	122,929	65,926
Long-Term Debt	60,000	75,000	105,000	-	-	-
Long-Term Leases	6,812	7,468	8,500	6,552	6,678	6,501
Pension & Post-Retirement Benefits	2,738	2,234	2,640	3,294	3,350	3,322
Long-Term Deferred Tax Liabilities	866	909	10,817	1,013	983	1,009
Other Long-Term Liabilities	562	615	591	580	684	771
Total Liabilities	209,817	249,871	275,844	115,063	134,624	77,529

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	17,358	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	-	17,378	17,458	17,458	17,080	17,241
Retained Earnings	856,106	830,086	790,908	768,183	709,890	644,754
Treasury Stock	-62,334	-62,770	-63,063	-63,233	-54,161	-74,683
Comprehensive Income & Other	64,412	48,675	19,790	53,195	51,702	51,236
Total Common Equity	875,542	850,727	782,451	792,961	741,869	655,906
Minority Interest	6,015	5,917	5,751	5,644	5,944	5,768
Shareholders' Equity	881,557	856,644	788,202	798,605	747,813	661,674
Total Liabilities & Equity	1,091,374	1,106,515	1,064,046	913,668	882,437	739,203

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	109,988	120,935	146,678	8,862	9,168	8,802
Net Cash (Debt)	148,270	116,171	62,368	157,279	86,987	60,370
Net Cash Growth	186.87%	86.27%	-60.35%	80.81%	44.09%	9.82%
Net Cash Per Share	315.34	247.19	132.76	327.64	178.12	121.58
Filing Date Shares Outstanding	470.11	469.91	469.77	469.65	488.33	488.31
Total Common Shares Outstanding	470.11	469.91	469.77	469.65	488.33	488.24
Working Capital	321,694	304,663	306,808	309,972	222,172	215,340
Book Value Per Share	1862.43	1810.41	1665.59	1688.42	1519.18	1343.40
Tangible Book Value	510,610	474,492	431,224	735,673	672,735	591,172
Tangible Book Value Per Share	1086.16	1009.76	917.94	1566.44	1377.61	1210.81

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error